| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 9 May 2025 | 2 May 2025 |
| Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2025 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2024-25. Outcome of Board Meeting Recommended dividend of 7 (Seven) per equity share of 10 each (70%) for the financial year 2024-25, subject to approval of members at the ensuing Annual General Meeting (As Per BSE Announcement dated on 09.05.2025) | ||
| Board Meeting | 30 Jan 2025 | 22 Jan 2025 |
| HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2024 Outcome of Board Meeting held on 30 January 2025 (As Per BSE Announcement dated on 30.01.2025) | ||
| Board Meeting | 28 Oct 2024 | 21 Oct 2024 |
| HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on 28.10.2024) | ||
| Board Meeting | 2 Aug 2024 | 25 Jul 2024 |
| HESTER BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended 30 June 2024. Outcome of Board Meeting Financial Results Q1 FY25 (As Per BSE Announcement Dated on 02.08.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
